Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Cantor Fitzgerald
Teva
Merck
UBS
Moodys
Covington
Colorcon
Citi
Boehringer Ingelheim

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018706

« Back to Dashboard

NDA 018706 describes HYDERGINE LC, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the HYDERGINE LC profile page.

The generic ingredient in HYDERGINE LC is ergoloid mesylates. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ergoloid mesylates profile page.
Summary for 018706
Tradename:HYDERGINE LC
Applicant:Novartis
Ingredient:ergoloid mesylates
Patents:0
Therapeutic Class:Antidementia Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018706

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength1MG
Approval Date:Jan 18, 1983TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
Cipla
Citi
AstraZeneca
Boehringer Ingelheim
Teva
UBS
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot